Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

Bullboard (NDAQ:LMNL)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by Steve33on Feb 17, 2022 9:56am

Stockbuphoon

The companies that know the clinical data on the 4050 pbi indications that almost made a supposed deal with Pierre could buy Liminal for next to nothing getting their cash and small molecule assets ...more  
200
Discussion
Comment by stockbuphoonon Feb 16, 2022 1:59pm

RE:RE:Repays its Secured Debt Ending its Creditor Relationship

33, I threw out my thoughts from what I've seen through press releases over past few years. What's your read about this press release? Good news? Bad news? Prospects? Dead duck?  & ...more  
122
Discussion
Comment by stockbuphoonon Feb 16, 2022 1:05pm

RE:RE:RE:Repays its Secured Debt Ending its Creditor Relationship

When a company that has relatively cheap financing for a pre-revenue company and decides to pay a loan back, they are signalling that they cannot use the money for anything valuable like a clinical ...more  
165
Discussion
Comment by PLITheOneon Feb 16, 2022 11:20am

RE:MINUS $ 39 MILLIONS

ALDO has loaded up the truck many times now and has always lost  This won't be any different. If you invest in a company run by criminals who intentionally mislead and lie to investors ...more  
144
Discussion
Post by 4Justiceon Feb 16, 2022 10:12am

MINUS $ 39 MILLIONS

They repay SALP of $39 millions and still have to pay $9 milliuons a year for the Winnipeg plant contract. They are seriously going to have to think about an IPO and after two months the Market shows ...more  
198
Discussion
Comment by aldo451on Feb 16, 2022 8:59am

RE:RE:Repays its Secured Debt Ending its Creditor Relationship

Exactly my thoughts 33, but no worries, they will put a negative spin on it...it's all part of the evil  plan. 
91
Discussion
Comment by 37minus4on Feb 16, 2022 8:51am

RE:Repays its Secured Debt Ending its Creditor Relationship

So much for that theory. What is the new "evil-genius" version? ;-) 33
77
Discussion
Post by 37minus4on Feb 16, 2022 8:50am

Repays its Secured Debt Ending its Creditor Relationship

Liminal BioSciences Repays its Secured Debt Ending its Creditor Relationship with Structured Alpha LP Repayment eliminates total debt of $39.1M Early Repayment results in:   ...more  
177
Discussion
Comment by stockbuphoonon Feb 14, 2022 12:47pm

RE:Will they release pk data re 4050 they said results are so b

Bingo, Ed. This scenario seems to be playing out. When they removed IPF from clinical trial planning in May 2021 and said that they would need until end of 2021 (another 7 months) to see if there is ...more  
168
Discussion
Post by edroseon Feb 12, 2022 10:02am

Will they release pk data re 4050 they said results are so b

Bad they decided to put further research re 4050 on hold  then they turn around and make deal and pay pierre laurin for parent molecule of 4050  If 4050 is worthless like they want us to ...more  
250
Discussion
Comment by stockbuphoonon Feb 10, 2022 12:31pm

RE:been a long time and nothing

What is wrong with you, GunnerG? Do you really need to make fun of people who lost life savings or substantial losses in a very suspicious way with Thomvest taking over with some financial ...more  
145
Discussion
Post by 4Justiceon Feb 10, 2022 9:48am

GOON NER

It was the comment of a guywho knows noithing about the lawsuit and even less about what is going on at Liminal. Goonner, it's a $1 billion horse race. Only two horses are at the starting gate ...more  
153
Post by GunnerGon Feb 09, 2022 10:10pm

been a long time and nothing

from the lawyers on your great suit?   Discovery in 2022?  How many years has it been? Keep paying those legal fees.  ROF
153
Discussion
Post by edroseon Feb 09, 2022 4:15pm

STOCKBUPHON Who will the judge believe reputable scientist

And pierre laurin  remember all the presentations they showed investors SHOWING GREAT RESULTS  like ryplasim and better than expected results in alstrom study the great positive impact on ...more  
167
Post by edroseon Feb 09, 2022 4:07pm

Stockbuffon the lawyers will question the scientists

Lynne gagnon and John Moran are respected scientist it was raised several times WHY DID THEY GET RID OF CHIEF SCIENTIST and most of her key staff when they wiped out retail investors 
104
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities